Mifepristone Manufacturer Wins First Round in West Virginia
Drug & Device Law
MAY 19, 2023
The core premise of Bexis’ article is very simple: Once the FDA has said “yes” and approved a particular drug for a particular indication (“intended use”) for sale in the United States, federal preemption precludes any state from saying say “no” and trying to ban that same FDA-approved drug. T]he growing market for mifepristone. . .
Let's personalize your content